
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
OTULIN CRISPR/Cas9 KO Plasmid (h) | sc-407676 | 20 µg | $397.00 | |||
OTULIN HDR Plasmid (h) | sc-407676-HDR | 20 µg | $445.00 |
OTULIN encodes a deubiquitinase that selectively hydrolyzes linear (M1-linked) ubiquitin chains, acting as a key negative regulator of LUBAC-dependent ubiquitin signaling. By editing ubiquitin architectures on signaling complexes, OTULIN modulates TNF receptor and innate immune pathways, shaping NF-κB activation, cell death decisions, and inflammatory gene expression programs. OTULIN function is tightly linked to immune homeostasis, and its dysregulation has been associated with autoinflammatory phenotypes and altered cytokine signaling. In cell models, perturbing OTULIN helps dissect how linear ubiquitination controls signal termination, proteostasis, and stress responses.
OTULIN CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the OTULIN gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the OTULIN locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, OTULIN HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined OTULIN target site.
When co-transfected with OTULIN CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the OTULIN locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.